The global Anti Influenza Virus Chinese Medicine market size was valued at US$ 3.25 billion in 2024 and is projected to reach US$ 4.85 billion by 2030, at a CAGR of 6.9%
The United States Anti Influenza Virus Chinese Medicine market size was valued at US$ 285.4 million in 2024 and is projected to reach US$ 438.6 million by 2030, at a CAGR of 7.4%
Traditional Chinese medicine formulations specifically for influenza treatment. Materials incorporate validated antiviral herbal compounds. Products require efficacy validation and quality control.
Healthcare sector represents 70% share. Production standardization improved 35%. Clinical validation at 95%. Manufacturing efficiency increased 30%. Applications: healthcare (70%), retail (20%), institutional (10%). Research validation enhanced efficacy 28%. China leads with 65% share. Modern formulations grew 42%. Clinical partnerships increased 45%. Quality control represents 18% of costs. Innovation focuses on evidence-based approaches. Respiratory health shows 38% growth.
Report Overview
Anti influenza virus Chinese medicine refers to traditional Chinese medicine remedies and formulations used to prevent and treat influenza infections.
This report provides a deep insight into the global Anti Influenza Virus Chinese Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti Influenza Virus Chinese Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti Influenza Virus Chinese Medicine market in any manner.
Global Anti Influenza Virus Chinese Medicine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Guangzhou Pharmaceutical
CR SANJIU
TASLY
China TCM
Yunnan Baiyao
Tongrentang
Jumpcan
Zhejiang Conba Pharmaceutical
Green Valley Pharma
Changbaishan Pharmaceutical
Zhejiang Kanglaite Pharmaceutical
Qingfeng Pharmaceutical Group
Buchang Pharmaceutical
Livzon
ZBD Pharmaceutical
Chase Sun Pharmaceutical
Wuzhou Pharmaceutical
Yusheng Pharmaceutical
Harbin Pharmaceutical Group
Fusen Pharmaceutical
Gerun Pharmaceutical
Shineway Pharmaceutical
Yiling Pharmaceutical
Harbin Pharmaceutical Group
Market Segmentation (by Type)
Oral Solution
Capsule
Lozenges
Chewable Tablets
Aerosol
Injection
Pills
Particles
Syrup
Market Segmentation (by Application)
Adult
Children
Geographic Segmentation
2025North America (USA, Canada, Mexico)
2025Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
2025Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
2025South America (Brazil, Argentina, Columbia, Rest of South America)
2025The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
2025Industry drivers, restraints, and opportunities covered in the study
2025Neutral perspective on the market performance
2025Recent industry trends and developments
2025Competitive landscape & strategies of key players
2025Potential & niche segments and regions exhibiting promising growth covered
2025Historical, current, and projected market size, in terms of value
2025In-depth analysis of the Anti Influenza Virus Chinese Medicine Market
2025Overview of the regional outlook of the Anti Influenza Virus Chinese Medicine Market:
Key Reasons to Buy this Report:
2025Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
2025This enables you to anticipate market changes to remain ahead of your competitors
2025You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
2025The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
2025Provision of market value (USD Billion) data for each segment and sub-segment
2025Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
2025Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
2025Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
2025Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
2025The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
2025Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Anti Influenza Virus Chinese Medicine
1.2 Key Market Segments
1.2.1 Anti Influenza Virus Chinese Medicine Segment by Type
1.2.2 Anti Influenza Virus Chinese Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Anti Influenza Virus Chinese Medicine Market Overview
2.1 Global Market Overview
2.1.1 Global Anti Influenza Virus Chinese Medicine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti Influenza Virus Chinese Medicine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Anti Influenza Virus Chinese Medicine Market Competitive Landscape
3.1 Global Anti Influenza Virus Chinese Medicine Sales by Manufacturers (2019-2025)
3.2 Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Manufacturers (2019-2025)
3.3 Anti Influenza Virus Chinese Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti Influenza Virus Chinese Medicine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Anti Influenza Virus Chinese Medicine Sales Sites, Area Served, Product Type
3.6 Anti Influenza Virus Chinese Medicine Market Competitive Situation and Trends
3.6.1 Anti Influenza Virus Chinese Medicine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti Influenza Virus Chinese Medicine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Anti Influenza Virus Chinese Medicine Industry Chain Analysis
4.1 Anti Influenza Virus Chinese Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Anti Influenza Virus Chinese Medicine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Anti Influenza Virus Chinese Medicine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2019-2025)
6.3 Global Anti Influenza Virus Chinese Medicine Market Size Market Share by Type (2019-2025)
6.4 Global Anti Influenza Virus Chinese Medicine Price by Type (2019-2025)
7 Anti Influenza Virus Chinese Medicine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti Influenza Virus Chinese Medicine Market Sales by Application (2019-2025)
7.3 Global Anti Influenza Virus Chinese Medicine Market Size (M USD) by Application (2019-2025)
7.4 Global Anti Influenza Virus Chinese Medicine Sales Growth Rate by Application (2019-2025)
8 Anti Influenza Virus Chinese Medicine Market Segmentation by Region
8.1 Global Anti Influenza Virus Chinese Medicine Sales by Region
8.1.1 Global Anti Influenza Virus Chinese Medicine Sales by Region
8.1.2 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region
8.2 North America
8.2.1 North America Anti Influenza Virus Chinese Medicine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti Influenza Virus Chinese Medicine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti Influenza Virus Chinese Medicine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti Influenza Virus Chinese Medicine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Guangzhou Pharmaceutical
9.1.1 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.1.2 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.1.3 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.1.4 Guangzhou Pharmaceutical Business Overview
9.1.5 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine SWOT Analysis
9.1.6 Guangzhou Pharmaceutical Recent Developments
9.2 CR SANJIU
9.2.1 CR SANJIU Anti Influenza Virus Chinese Medicine Basic Information
9.2.2 CR SANJIU Anti Influenza Virus Chinese Medicine Product Overview
9.2.3 CR SANJIU Anti Influenza Virus Chinese Medicine Product Market Performance
9.2.4 CR SANJIU Business Overview
9.2.5 CR SANJIU Anti Influenza Virus Chinese Medicine SWOT Analysis
9.2.6 CR SANJIU Recent Developments
9.3 TASLY
9.3.1 TASLY Anti Influenza Virus Chinese Medicine Basic Information
9.3.2 TASLY Anti Influenza Virus Chinese Medicine Product Overview
9.3.3 TASLY Anti Influenza Virus Chinese Medicine Product Market Performance
9.3.4 TASLY Anti Influenza Virus Chinese Medicine SWOT Analysis
9.3.5 TASLY Business Overview
9.3.6 TASLY Recent Developments
9.4 China TCM
9.4.1 China TCM Anti Influenza Virus Chinese Medicine Basic Information
9.4.2 China TCM Anti Influenza Virus Chinese Medicine Product Overview
9.4.3 China TCM Anti Influenza Virus Chinese Medicine Product Market Performance
9.4.4 China TCM Business Overview
9.4.5 China TCM Recent Developments
9.5 Yunnan Baiyao
9.5.1 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Basic Information
9.5.2 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product Overview
9.5.3 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product Market Performance
9.5.4 Yunnan Baiyao Business Overview
9.5.5 Yunnan Baiyao Recent Developments
9.6 Tongrentang
9.6.1 Tongrentang Anti Influenza Virus Chinese Medicine Basic Information
9.6.2 Tongrentang Anti Influenza Virus Chinese Medicine Product Overview
9.6.3 Tongrentang Anti Influenza Virus Chinese Medicine Product Market Performance
9.6.4 Tongrentang Business Overview
9.6.5 Tongrentang Recent Developments
9.7 Jumpcan
9.7.1 Jumpcan Anti Influenza Virus Chinese Medicine Basic Information
9.7.2 Jumpcan Anti Influenza Virus Chinese Medicine Product Overview
9.7.3 Jumpcan Anti Influenza Virus Chinese Medicine Product Market Performance
9.7.4 Jumpcan Business Overview
9.7.5 Jumpcan Recent Developments
9.8 Zhejiang Conba Pharmaceutical
9.8.1 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.8.2 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.8.3 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.8.4 Zhejiang Conba Pharmaceutical Business Overview
9.8.5 Zhejiang Conba Pharmaceutical Recent Developments
9.9 Green Valley Pharma
9.9.1 Green Valley Pharma Anti Influenza Virus Chinese Medicine Basic Information
9.9.2 Green Valley Pharma Anti Influenza Virus Chinese Medicine Product Overview
9.9.3 Green Valley Pharma Anti Influenza Virus Chinese Medicine Product Market Performance
9.9.4 Green Valley Pharma Business Overview
9.9.5 Green Valley Pharma Recent Developments
9.10 Changbaishan Pharmaceutical
9.10.1 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.10.2 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.10.3 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.10.4 Changbaishan Pharmaceutical Business Overview
9.10.5 Changbaishan Pharmaceutical Recent Developments
9.11 Zhejiang Kanglaite Pharmaceutical
9.11.1 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.11.2 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.11.3 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.11.4 Zhejiang Kanglaite Pharmaceutical Business Overview
9.11.5 Zhejiang Kanglaite Pharmaceutical Recent Developments
9.12 Qingfeng Pharmaceutical Group
9.12.1 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Basic Information
9.12.2 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Overview
9.12.3 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Market Performance
9.12.4 Qingfeng Pharmaceutical Group Business Overview
9.12.5 Qingfeng Pharmaceutical Group Recent Developments
9.13 Buchang Pharmaceutical
9.13.1 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.13.2 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.13.3 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.13.4 Buchang Pharmaceutical Business Overview
9.13.5 Buchang Pharmaceutical Recent Developments
9.14 Livzon
9.14.1 Livzon Anti Influenza Virus Chinese Medicine Basic Information
9.14.2 Livzon Anti Influenza Virus Chinese Medicine Product Overview
9.14.3 Livzon Anti Influenza Virus Chinese Medicine Product Market Performance
9.14.4 Livzon Business Overview
9.14.5 Livzon Recent Developments
9.15 ZBD Pharmaceutical
9.15.1 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.15.2 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.15.3 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.15.4 ZBD Pharmaceutical Business Overview
9.15.5 ZBD Pharmaceutical Recent Developments
9.16 Chase Sun Pharmaceutical
9.16.1 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.16.2 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.16.3 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.16.4 Chase Sun Pharmaceutical Business Overview
9.16.5 Chase Sun Pharmaceutical Recent Developments
9.17 Wuzhou Pharmaceutical
9.17.1 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.17.2 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.17.3 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.17.4 Wuzhou Pharmaceutical Business Overview
9.17.5 Wuzhou Pharmaceutical Recent Developments
9.18 Yusheng Pharmaceutical
9.18.1 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.18.2 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.18.3 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.18.4 Yusheng Pharmaceutical Business Overview
9.18.5 Yusheng Pharmaceutical Recent Developments
9.19 Harbin Pharmaceutical Group
9.19.1 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Basic Information
9.19.2 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Overview
9.19.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Market Performance
9.19.4 Harbin Pharmaceutical Group Business Overview
9.19.5 Harbin Pharmaceutical Group Recent Developments
9.20 Fusen Pharmaceutical
9.20.1 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.20.2 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.20.3 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.20.4 Fusen Pharmaceutical Business Overview
9.20.5 Fusen Pharmaceutical Recent Developments
9.21 Gerun Pharmaceutical
9.21.1 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.21.2 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.21.3 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.21.4 Gerun Pharmaceutical Business Overview
9.21.5 Gerun Pharmaceutical Recent Developments
9.22 Shineway Pharmaceutical
9.22.1 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.22.2 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.22.3 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.22.4 Shineway Pharmaceutical Business Overview
9.22.5 Shineway Pharmaceutical Recent Developments
9.23 Yiling Pharmaceutical
9.23.1 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
9.23.2 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
9.23.3 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product Market Performance
9.23.4 Yiling Pharmaceutical Business Overview
9.23.5 Yiling Pharmaceutical Recent Developments
9.24 Harbin Pharmaceutical Group
9.24.1 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Basic Information
9.24.2 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Overview
9.24.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Market Performance
9.24.4 Harbin Pharmaceutical Group Business Overview
9.24.5 Harbin Pharmaceutical Group Recent Developments
10 Anti Influenza Virus Chinese Medicine Market Forecast by Region
10.1 Global Anti Influenza Virus Chinese Medicine Market Size Forecast
10.2 Global Anti Influenza Virus Chinese Medicine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti Influenza Virus Chinese Medicine Market Size Forecast by Country
10.2.3 Asia Pacific Anti Influenza Virus Chinese Medicine Market Size Forecast by Region
10.2.4 South America Anti Influenza Virus Chinese Medicine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti Influenza Virus Chinese Medicine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Anti Influenza Virus Chinese Medicine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti Influenza Virus Chinese Medicine by Type (2025-2030)
11.1.2 Global Anti Influenza Virus Chinese Medicine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti Influenza Virus Chinese Medicine by Type (2025-2030)
11.2 Global Anti Influenza Virus Chinese Medicine Market Forecast by Application (2025-2030)
11.2.1 Global Anti Influenza Virus Chinese Medicine Sales (Kilotons) Forecast by Application
11.2.2 Global Anti Influenza Virus Chinese Medicine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti Influenza Virus Chinese Medicine Market Size Comparison by Region (M USD)
Table 5. Global Anti Influenza Virus Chinese Medicine Sales (Kilotons) by Manufacturers (2019-2025)
Table 6. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Anti Influenza Virus Chinese Medicine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Anti Influenza Virus Chinese Medicine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Influenza Virus Chinese Medicine as of 2022)
Table 10. Global Market Anti Influenza Virus Chinese Medicine Average Price (USD/Ton) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Anti Influenza Virus Chinese Medicine Sales Sites and Area Served
Table 12. Manufacturers Anti Influenza Virus Chinese Medicine Product Type
Table 13. Global Anti Influenza Virus Chinese Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti Influenza Virus Chinese Medicine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti Influenza Virus Chinese Medicine Market Challenges
Table 22. Global Anti Influenza Virus Chinese Medicine Sales by Type (Kilotons)
Table 23. Global Anti Influenza Virus Chinese Medicine Market Size by Type (M USD)
Table 24. Global Anti Influenza Virus Chinese Medicine Sales (Kilotons) by Type (2019-2025)
Table 25. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2019-2025)
Table 26. Global Anti Influenza Virus Chinese Medicine Market Size (M USD) by Type (2019-2025)
Table 27. Global Anti Influenza Virus Chinese Medicine Market Size Share by Type (2019-2025)
Table 28. Global Anti Influenza Virus Chinese Medicine Price (USD/Ton) by Type (2019-2025)
Table 29. Global Anti Influenza Virus Chinese Medicine Sales (Kilotons) by Application
Table 30. Global Anti Influenza Virus Chinese Medicine Market Size by Application
Table 31. Global Anti Influenza Virus Chinese Medicine Sales by Application (2019-2025) & (Kilotons)
Table 32. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2019-2025)
Table 33. Global Anti Influenza Virus Chinese Medicine Sales by Application (2019-2025) & (M USD)
Table 34. Global Anti Influenza Virus Chinese Medicine Market Share by Application (2019-2025)
Table 35. Global Anti Influenza Virus Chinese Medicine Sales Growth Rate by Application (2019-2025)
Table 36. Global Anti Influenza Virus Chinese Medicine Sales by Region (2019-2025) & (Kilotons)
Table 37. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2019-2025)
Table 38. North America Anti Influenza Virus Chinese Medicine Sales by Country (2019-2025) & (Kilotons)
Table 39. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2019-2025) & (Kilotons)
Table 40. Asia Pacific Anti Influenza Virus Chinese Medicine Sales by Region (2019-2025) & (Kilotons)
Table 41. South America Anti Influenza Virus Chinese Medicine Sales by Country (2019-2025) & (Kilotons)
Table 42. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Region (2019-2025) & (Kilotons)
Table 43. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 44. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 45. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 46. Guangzhou Pharmaceutical Business Overview
Table 47. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine SWOT Analysis
Table 48. Guangzhou Pharmaceutical Recent Developments
Table 49. CR SANJIU Anti Influenza Virus Chinese Medicine Basic Information
Table 50. CR SANJIU Anti Influenza Virus Chinese Medicine Product Overview
Table 51. CR SANJIU Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 52. CR SANJIU Business Overview
Table 53. CR SANJIU Anti Influenza Virus Chinese Medicine SWOT Analysis
Table 54. CR SANJIU Recent Developments
Table 55. TASLY Anti Influenza Virus Chinese Medicine Basic Information
Table 56. TASLY Anti Influenza Virus Chinese Medicine Product Overview
Table 57. TASLY Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 58. TASLY Anti Influenza Virus Chinese Medicine SWOT Analysis
Table 59. TASLY Business Overview
Table 60. TASLY Recent Developments
Table 61. China TCM Anti Influenza Virus Chinese Medicine Basic Information
Table 62. China TCM Anti Influenza Virus Chinese Medicine Product Overview
Table 63. China TCM Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 64. China TCM Business Overview
Table 65. China TCM Recent Developments
Table 66. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Basic Information
Table 67. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product Overview
Table 68. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 69. Yunnan Baiyao Business Overview
Table 70. Yunnan Baiyao Recent Developments
Table 71. Tongrentang Anti Influenza Virus Chinese Medicine Basic Information
Table 72. Tongrentang Anti Influenza Virus Chinese Medicine Product Overview
Table 73. Tongrentang Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 74. Tongrentang Business Overview
Table 75. Tongrentang Recent Developments
Table 76. Jumpcan Anti Influenza Virus Chinese Medicine Basic Information
Table 77. Jumpcan Anti Influenza Virus Chinese Medicine Product Overview
Table 78. Jumpcan Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 79. Jumpcan Business Overview
Table 80. Jumpcan Recent Developments
Table 81. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 82. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 83. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 84. Zhejiang Conba Pharmaceutical Business Overview
Table 85. Zhejiang Conba Pharmaceutical Recent Developments
Table 86. Green Valley Pharma Anti Influenza Virus Chinese Medicine Basic Information
Table 87. Green Valley Pharma Anti Influenza Virus Chinese Medicine Product Overview
Table 88. Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 89. Green Valley Pharma Business Overview
Table 90. Green Valley Pharma Recent Developments
Table 91. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 92. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 93. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 94. Changbaishan Pharmaceutical Business Overview
Table 95. Changbaishan Pharmaceutical Recent Developments
Table 96. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 97. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 98. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 99. Zhejiang Kanglaite Pharmaceutical Business Overview
Table 100. Zhejiang Kanglaite Pharmaceutical Recent Developments
Table 101. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Basic Information
Table 102. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Overview
Table 103. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 104. Qingfeng Pharmaceutical Group Business Overview
Table 105. Qingfeng Pharmaceutical Group Recent Developments
Table 106. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 107. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 108. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 109. Buchang Pharmaceutical Business Overview
Table 110. Buchang Pharmaceutical Recent Developments
Table 111. Livzon Anti Influenza Virus Chinese Medicine Basic Information
Table 112. Livzon Anti Influenza Virus Chinese Medicine Product Overview
Table 113. Livzon Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 114. Livzon Business Overview
Table 115. Livzon Recent Developments
Table 116. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 117. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 118. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 119. ZBD Pharmaceutical Business Overview
Table 120. ZBD Pharmaceutical Recent Developments
Table 121. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 122. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 123. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 124. Chase Sun Pharmaceutical Business Overview
Table 125. Chase Sun Pharmaceutical Recent Developments
Table 126. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 127. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 128. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 129. Wuzhou Pharmaceutical Business Overview
Table 130. Wuzhou Pharmaceutical Recent Developments
Table 131. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 132. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 133. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 134. Yusheng Pharmaceutical Business Overview
Table 135. Yusheng Pharmaceutical Recent Developments
Table 136. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Basic Information
Table 137. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Overview
Table 138. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 139. Harbin Pharmaceutical Group Business Overview
Table 140. Harbin Pharmaceutical Group Recent Developments
Table 141. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 142. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 143. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 144. Fusen Pharmaceutical Business Overview
Table 145. Fusen Pharmaceutical Recent Developments
Table 146. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 147. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 148. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 149. Gerun Pharmaceutical Business Overview
Table 150. Gerun Pharmaceutical Recent Developments
Table 151. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 152. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 153. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 154. Shineway Pharmaceutical Business Overview
Table 155. Shineway Pharmaceutical Recent Developments
Table 156. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Basic Information
Table 157. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product Overview
Table 158. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 159. Yiling Pharmaceutical Business Overview
Table 160. Yiling Pharmaceutical Recent Developments
Table 161. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Basic Information
Table 162. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Overview
Table 163. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 164. Harbin Pharmaceutical Group Business Overview
Table 165. Harbin Pharmaceutical Group Recent Developments
Table 166. Global Anti Influenza Virus Chinese Medicine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 167. Global Anti Influenza Virus Chinese Medicine Market Size Forecast by Region (2025-2030) & (M USD)
Table 168. North America Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 169. North America Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 170. Europe Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 171. Europe Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 172. Asia Pacific Anti Influenza Virus Chinese Medicine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 173. Asia Pacific Anti Influenza Virus Chinese Medicine Market Size Forecast by Region (2025-2030) & (M USD)
Table 174. South America Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 175. South America Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 176. Middle East and Africa Anti Influenza Virus Chinese Medicine Consumption Forecast by Country (2025-2030) & (Units)
Table 177. Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 178. Global Anti Influenza Virus Chinese Medicine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 179. Global Anti Influenza Virus Chinese Medicine Market Size Forecast by Type (2025-2030) & (M USD)
Table 180. Global Anti Influenza Virus Chinese Medicine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 181. Global Anti Influenza Virus Chinese Medicine Sales (Kilotons) Forecast by Application (2025-2030)
Table 182. Global Anti Influenza Virus Chinese Medicine Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Anti Influenza Virus Chinese Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti Influenza Virus Chinese Medicine Market Size (M USD), 2019-2030
Figure 5. Global Anti Influenza Virus Chinese Medicine Market Size (M USD) (2019-2030)
Figure 6. Global Anti Influenza Virus Chinese Medicine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti Influenza Virus Chinese Medicine Market Size by Country (M USD)
Figure 11. Anti Influenza Virus Chinese Medicine Sales Share by Manufacturers in 2023
Figure 12. Global Anti Influenza Virus Chinese Medicine Revenue Share by Manufacturers in 2023
Figure 13. Anti Influenza Virus Chinese Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti Influenza Virus Chinese Medicine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti Influenza Virus Chinese Medicine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti Influenza Virus Chinese Medicine Market Share by Type
Figure 18. Sales Market Share of Anti Influenza Virus Chinese Medicine by Type (2019-2025)
Figure 19. Sales Market Share of Anti Influenza Virus Chinese Medicine by Type in 2023
Figure 20. Market Size Share of Anti Influenza Virus Chinese Medicine by Type (2019-2025)
Figure 21. Market Size Market Share of Anti Influenza Virus Chinese Medicine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti Influenza Virus Chinese Medicine Market Share by Application
Figure 24. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2019-2025)
Figure 25. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application in 2023
Figure 26. Global Anti Influenza Virus Chinese Medicine Market Share by Application (2019-2025)
Figure 27. Global Anti Influenza Virus Chinese Medicine Market Share by Application in 2023
Figure 28. Global Anti Influenza Virus Chinese Medicine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2019-2025)
Figure 30. North America Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 31. North America Anti Influenza Virus Chinese Medicine Sales Market Share by Country in 2023
Figure 32. U.S. Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 33. Canada Anti Influenza Virus Chinese Medicine Sales (Kilotons) and Growth Rate (2019-2025)
Figure 34. Mexico Anti Influenza Virus Chinese Medicine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 36. Europe Anti Influenza Virus Chinese Medicine Sales Market Share by Country in 2023
Figure 37. Germany Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 38. France Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 39. U.K. Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 40. Italy Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 41. Russia Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 42. Asia Pacific Anti Influenza Virus Chinese Medicine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anti Influenza Virus Chinese Medicine Sales Market Share by Region in 2023
Figure 44. China Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 45. Japan Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 46. South Korea Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 47. India Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 48. Southeast Asia Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 49. South America Anti Influenza Virus Chinese Medicine Sales and Growth Rate (Kilotons)
Figure 50. South America Anti Influenza Virus Chinese Medicine Sales Market Share by Country in 2023
Figure 51. Brazil Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 52. Argentina Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 53. Columbia Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 54. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 57. UAE Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 58. Egypt Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 59. Nigeria Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 60. South Africa Anti Influenza Virus Chinese Medicine Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 61. Global Anti Influenza Virus Chinese Medicine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anti Influenza Virus Chinese Medicine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti Influenza Virus Chinese Medicine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti Influenza Virus Chinese Medicine Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti Influenza Virus Chinese Medicine Sales Forecast by Application (2025-2030)
Figure 66. Global Anti Influenza Virus Chinese Medicine Market Share Forecast by Application (2025-2030)
